Methods for use of a specific anti-angiogenic adenoviral agent

Details for Australian Patent Application No. 2011204405 (hide)

Owner Vascular Biogenics Ltd.

Inventors Cohen, Yael; Sher, Naamit; Feige, Erez; Bangio, Livnat; Breitbart, Eyal

Agent Cullens

Pub. Number AU-A-2011204405

PCT Pub. Number WO2011/083464

Priority 61/282,247 07.01.10 US; 61/282,228 05.01.10 US

Filing date 5 January 2011

Wipo publication date 14 July 2011

International Classifications

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/00 Mutation or genetic engineering

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/083464 Priority application(s): WO2011/083464

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011204406-Treatment with VB-201

2011204404-Desaturases of a green microalga and uses thereof